Thermo Fisher Scientific Inc. (TMO) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 22.32B | 28.71B | 22.3B | 24.58B | 23.38B | 22.14B | 23.78B | 25.48B | 23.64B | 24.59B | 23.09B | 20B |
| Cash & Short-Term Investments | 3.26B | 10.11B | 3.55B | 6.39B | 5.95B | 5.57B | 6.64B | 8.83B | 7.26B | 8.08B | 6.15B | 3.13B |
| Cash Only | 3.25B | 9.86B | 1.98B | 4.58B | 4.13B | 4.01B | 4.64B | 7.08B | 5.51B | 8.08B | 6.15B | 3.13B |
| Short-Term Investments | 2M | 253M | 1.56B | 1.81B | 1.81B | 1.56B | 2B | 1.75B | 1.75B | 0 | 0 | 0 |
| Accounts Receivable | 9.2B | 10.57B | 8.91B | 10.04B | 9.82B | 9.63B | 9.8B | 9.43B | 9.35B | 9.66B | 9.84B | 9.49B |
| Days Sales Outstanding | 78.15 | 75.74 | 77.51 | 83.23 | 82.56 | 80.11 | 82.54 | 81.08 | 82.72 | 82.4 | 83.14 | 79.97 |
| Inventory | 5.5B | 5.42B | 5.75B | 5.56B | 5.22B | 4.98B | 5.43B | 5.2B | 5.13B | 5.09B | 5.4B | 5.66B |
| Days Inventory Outstanding | 72.76 | 70.01 | 79.49 | 72.08 | 73.36 | 70.61 | 77.31 | 75.85 | 75.06 | 69.61 | 80.61 | 80.25 |
| Other Current Assets | 4.36B | 2.61B | 4.09B | 2.6B | 2.39B | 1.96B | 1.91B | 2.02B | 1.9B | 1.76B | 1.7B | 1.72B |
| Total Non-Current Assets | 90.97B | 81.64B | 80.72B | 76.65B | 75.66B | 75.18B | 76.58B | 73.02B | 73.45B | 74.14B | 73.97B | 74.11B |
| Property, Plant & Equipment | 10.66B | 12.01B | 10.18B | 9.63B | 9.33B | 10.79B | 9.41B | 9.28B | 9.32B | 11B | 9.17B | 9.29B |
| Fixed Asset Turnover | 0.97x | 1.10x | 1.12x | 1.14x | 1.03x | 1.13x | 1.13x | 1.13x | 1.02x | 1.08x | 1.15x | 1.15x |
| Goodwill | 55.19B | 49.36B | 49.29B | 47.25B | 46.49B | 45.85B | 46.73B | 43.84B | 43.84B | 44.02B | 43.58B | 43.27B |
| Intangible Assets | 19.15B | 15.84B | 16.24B | 15.15B | 15.32B | 15.53B | 16.26B | 15.52B | 16.05B | 16.67B | 17.09B | 17.44B |
| Long-Term Investments | 0 | 541M | 435M | 198M | 374M | 560M | 106M | 492M | 233M | 59M | 94M | 13M |
| Other Non-Current Assets | 5.97B | 3.88B | 4.58B | 4.42B | 4.14B | 2.44B | 4.08B | 3.88B | 4.01B | 2.38B | 4.03B | 4.09B |
| Total Assets | 113.28B | 110.34B | 103.02B | 101.23B | 99.04B | 97.32B | 100.36B | 98.5B | 97.09B | 98.73B | 97.06B | 94.11B |
| Asset Turnover | 0.10x | 0.11x | 0.11x | 0.11x | 0.11x | 0.12x | 0.11x | 0.11x | 0.11x | 0.11x | 0.11x | 0.11x |
| Asset Growth % | 14.38% | 13.38% | 2.65% | 2.78% | 2% | -1.42% | 3.41% | 4.67% | 2.57% | 1.62% | 7.2% | 3.89% |
| Total Current Liabilities | 14.62B | 15.19B | 14.89B | 12.72B | 13.17B | 13.33B | 14.6B | 14.77B | 13.94B | 14.01B | 14.16B | 14.11B |
| Accounts Payable | 0 | 3.62B | 2.98B | 2.98B | 3.05B | 3.08B | 2.61B | 2.55B | 2.56B | 2.87B | 2.51B | 2.42B |
| Days Payables Outstanding | - | 41.38 | 41.91 | 40.3 | 44.06 | 38.57 | 37.48 | 37.46 | 39.85 | 35.7 | 35.94 | 37.01 |
| Short-Term Debt | 3.09B | 3.81B | 3.82B | 2.21B | 2.82B | 2.48B | 4.12B | 5.12B | 4.45B | 3.87B | 4.79B | 4.81B |
| Deferred Revenue (Current) | 0 | 2.71B | 2.85B | 2.81B | 2.87B | 2.85B | 2.66B | 2.59B | 2.63B | 2.69B | 2.55B | 2.59B |
| Other Current Liabilities | 11.53B | 3.05B | 3.25B | 1M | 3.02B | 2.94B | 3.39B | 3.02B | 2.98B | 2.98B | 2.85B | 2.98B |
| Current Ratio | 1.53x | 1.89x | 1.50x | 1.93x | 1.77x | 1.66x | 1.63x | 1.72x | 1.70x | 1.75x | 1.63x | 1.42x |
| Quick Ratio | 1.15x | 1.53x | 1.11x | 1.50x | 1.38x | 1.29x | 1.26x | 1.37x | 1.33x | 1.39x | 1.25x | 1.02x |
| Cash Conversion Cycle | - | 104.37 | 115.09 | 115.01 | 111.86 | 112.15 | 122.37 | 119.47 | 117.93 | 116.31 | 127.81 | 123.2 |
| Total Non-Current Liabilities | 46.72B | 41.62B | 37.11B | 37.91B | 36.38B | 34.32B | 36.66B | 36.19B | 37.53B | 37.87B | 37.44B | 36.08B |
| Long-Term Debt | 40.07B | 35.85B | 31.86B | 33.02B | 31.37B | 29.06B | 31.2B | 30.28B | 31.16B | 31.31B | 30.49B | 29.19B |
| Capital Lease Obligations | 0 | 1.2B | 0 | 0 | 0 | 1.24B | 0 | 0 | 0 | 1.24B | 0 | 0 |
| Deferred Tax Liabilities | 0 | 1.49B | 1.04B | 624M | 1.04B | 1.27B | 1.12B | 1.52B | 1.81B | 1.92B | 2.62B | 2.84B |
| Other Non-Current Liabilities | 6.65B | 1.9B | 3.09B | 3.15B | 2.84B | 1.61B | 2.92B | 2.94B | 3.14B | 1.9B | 2.98B | 2.94B |
| Total Liabilities | 61.34B | 56.81B | 52B | 50.63B | 49.55B | 47.65B | 51.27B | 50.96B | 51.47B | 51.88B | 51.59B | 50.19B |
| Total Debt | 43.16B | 40.85B | 35.68B | 35.23B | 34.19B | 32.77B | 35.31B | 35.41B | 35.61B | 36.42B | 35.28B | 34.01B |
| Net Debt | 39.91B | 31B | 33.7B | 30.65B | 30.04B | 28.76B | 30.66B | 28.32B | 30.1B | 28.34B | 29.12B | 30.86B |
| Debt / Equity | 0.83x | 0.76x | 0.70x | 0.70x | 0.69x | 0.66x | 0.72x | 0.74x | 0.78x | 0.78x | 0.78x | 0.77x |
| Debt / EBITDA | 18.82x | 13.49x | 13.69x | 13.54x | 13.43x | 10.89x | 13.30x | 13.90x | 13.93x | 12.87x | 12.48x | 12.90x |
| Net Debt / EBITDA | 17.40x | 10.23x | 12.93x | 11.78x | 11.80x | 9.55x | 11.54x | 11.11x | 11.78x | 10.01x | 10.30x | 11.71x |
| Interest Coverage | 5.31x | 6.82x | 6.27x | 5.23x | 6.35x | 6.06x | 5.11x | 5.19x | 5.37x | 4.92x | 5.49x | 5.39x |
| Total Equity | 52.06B | 53.54B | 51.15B | 50.6B | 49.48B | 49.67B | 49.1B | 47.53B | 45.62B | 46.84B | 45.46B | 43.91B |
| Equity Growth % | 5.21% | 7.78% | 4.18% | 6.45% | 8.46% | 6.04% | 8% | 8.24% | 7.52% | 6.1% | 3.97% | 3.4% |
| Book Value per Share | 139.57 | 142.01 | 135.33 | 133.87 | 130.57 | 129.69 | 127.86 | 124.11 | 118.81 | 120.73 | 117.18 | 113.18 |
| Total Shareholders' Equity | 51.94B | 53.41B | 51.02B | 50.51B | 49.39B | 49.58B | 48.99B | 47.43B | 45.52B | 46.73B | 45.33B | 43.75B |
| Common Stock | 0 | 445M | 444M | 444M | 444M | 444M | 444M | 443M | 443M | 442M | 442M | 441M |
| Retained Earnings | 0 | 59.16B | 55.9B | 55.9B | 54.45B | 53.1B | 51.42B | 49.94B | 48.54B | 47.36B | 45.87B | 44.29B |
| Treasury Stock | 0 | -22.31B | -21.27B | -21.27B | -21.27B | -19.23B | -18.23B | -18.19B | -18.19B | -15.13B | -15.12B | -15.08B |
| Accumulated OCI | 0 | -2.45B | -2.8B | -2.8B | -2.34B | -2.7B | -2.48B | -2.41B | -2.76B | -3.22B | -3.03B | -2.92B |
| Minority Interest | 121M | 129M | 129M | 91M | 95M | 87M | 107M | 103M | 107M | 107M | 136M | 163M |